SN
SanBio Company Limited
SNBIF · OTC
$16.45 +0.00% (+$0.00)
Market Cap ¥201.6B
P/E Ratio -
Div. Yield -
ROE 44.86%
Bulios Fair Price
$14.28
13.2% downside
Current Price
$16.45
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SNBIF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 15.92x
PEG N/A
P/E N/A
Growth
2 /100
Declining Book val. growth 4.67%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 21.70%
ROIC 26.90%
Asset turnover 0.00x
Debt
69 /100
Low Int. coverage -44.09x
Debt/Equity 0.09x
Current ratio 53.00x
Stability
32 /100
Unstable Profitable years 0
Beta 0.28x
EPS volatility 36.20%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SNBIF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Keita Mori
Employees
33
Headquarters
Tokyo
Upcoming events
14 DEC
Earnings
Upcoming earnings report